Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
CN |
|
Beijinghualian Hypermarket Co Ltd
SSE:600361
|
CN |
|
Haynes International Inc
NASDAQ:HAYN
|
US |
|
C
|
Ching Lee Holdings Ltd
HKEX:3728
|
HK |
Wuhan Easy Diagnosis Biomedicine Co Ltd
Wuhan Easy Diagnosis Biomedicine Co., Ltd. is engaged in the manufacturing and selling of the Diagnosis Biomedicine related equipment. The company is headquartered in Wuhan, Hubei and currently employs 1,144 full-time employees. The company went IPO on 2018-07-10. The firm's main products are POCT rapid diagnostic reagents, which can be divided into six categories: infectious diseases, cardiovascular and cerebrovascular diseases, kidney diseases, diabetes, gynecology and eugenics, and health checkups. The firm's main products are mainly used in domestic hospitals, health service centers, community clinics, medical examination centers and other medical institutions.
Wuhan Easy Diagnosis Biomedicine Co., Ltd. is engaged in the manufacturing and selling of the Diagnosis Biomedicine related equipment. The company is headquartered in Wuhan, Hubei and currently employs 1,144 full-time employees. The company went IPO on 2018-07-10. The firm's main products are POCT rapid diagnostic reagents, which can be divided into six categories: infectious diseases, cardiovascular and cerebrovascular diseases, kidney diseases, diabetes, gynecology and eugenics, and health checkups. The firm's main products are mainly used in domestic hospitals, health service centers, community clinics, medical examination centers and other medical institutions.
